FOLLOWUS
Classical Chinese Herbal Formulas in the Treatment of Coronary Heart Disease: A Narrative Review
Classical Chinese Herbal Formulas in the Treatment of Coronary Heart Disease: A Narrative Review
- Chinese Journal of Integrative Medicine 2021年27卷第1期 页码：70-79
- Affiliations：
1.Southern Branch of Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing (102618), China
2.Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing (100053),China
- Author bio：
Correspondence to: Dr. LI Jun, E-mail: gamyylijun@163.com
- Funds：dedicated funds from the State Administration of Traditional Chinese Medicine;the Twelfth Five-year Plan of China
DOI：10.1007/s11655-018-2574-5
中图分类号：纸质出版日期：2021-01-01，
网络出版日期：2018-11-27，
录用日期：2018-07-31
Scan for full text
Xin-hui LU, Jun LI. Classical Chinese Herbal Formulas in the Treatment of Coronary Heart Disease: A Narrative Review[J]. Chinese Journal of Integrative Medicine, 2021,27(1):70-79.
Xin-hui LU, Jun LI. Classical Chinese Herbal Formulas in the Treatment of Coronary Heart Disease: A Narrative Review[J]. Chinese Journal of Integrative Medicine, 2021,27(1):70-79.
Xin-hui LU, Jun LI. Classical Chinese Herbal Formulas in the Treatment of Coronary Heart Disease: A Narrative Review[J]. Chinese Journal of Integrative Medicine, 2021,27(1):70-79. DOI： 10.1007/s11655-018-2574-5.
Xin-hui LU, Jun LI. Classical Chinese Herbal Formulas in the Treatment of Coronary Heart Disease: A Narrative Review[J]. Chinese Journal of Integrative Medicine, 2021,27(1):70-79. DOI： 10.1007/s11655-018-2574-5.
摘要
Abstract
Objective:
2
To summarize the current evidence for 8 frequently prescribed Chinese herbal formulas (CHF) as treatments for angina pectoris in patients with coronary heart disease (CHD) and the associated adverse reactions.
Methods:
2
Seven electronic databases were screened from their inception through July 2018 for all evidence related to classical CHF for the treatment of patients with CHD.
Results:
2
CHF improves CHD outcomes in terms of angina pectoris
electrocardiogram results
Chinese medicine syndromes and biomarkers iomarkers. The combination of CHF and Western medicine (WM) is more effective on CHD than WM alone. The use of CHF to treat CHD shows the same or better clinical effects as the use of WM alone. The 8 investigated CHF do not induce hepatic and renal toxicity or other serious adverse effects.
Conclusions:
2
The safety and efficacy of 8 frequently prescribed herbal formulas for treating CHD have been confirmed in many studies. The findings of these studies are positive but should be interpreted cautiously due to the poor methodological quality of the randomized controlled trials (RCTs) and meta-analyses. Additional high-quality
multi-center
large-sample RCTs should be performed to confirm these results.
关键词
Keywords
Chinese herbal formulascoronary heart diseasecomplementary and alternative medicinereview
references
Mendis S, Puska P, Norrving B. Global atlas on cardiovascular disease prevention and control. Geneva: World Health Organization; 2011.
Zhu KF, Wang YM, Zhu JZ, et al. National prevalence of coronary heart disease and its relationship with human development index: a systematic review. Eur J Prev Cardiol 2016;23:530-543.
American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, O'Gara PT,Kushner FG, Ascheim DD, Casey DE, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction:executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013;61:485-510.
Hawk C, Ndetan H, Evans MW, Jr. Potential role of complementary and alternative health care providers in chronic disease prevention and health promotion: an analysis of National Health Interview Survey data. Prev Med 2012;54:18-22.
Hao P, Jiang F, Cheng J, et al. Traditional Chinese medicine for cardiovascular disease: evidence and potential mechanisms. J Am Coll Cardiol 2017;69:2952-2966.
Wang YP, Peng DH, Liu XQ. Meta-analysis of Gualou Xiebai Banxia Decoction for Xiongbi. Liaoning J Tradit Chin Med (Chin)2016;43:2051-2056.
Guo W, Liu XJ, Jia YQ, et al. Meta-analysis of Gualou Xiebai Banxia Decoction for stable angina pectoris. J Shanxi Coll Tradit Chin Med(Chin) 2012;13:69-71.
Qiu XE, Zhai C. Meta-analysis of Gualou Xiebai Banxia Decoction for unstable angina pectoris. Chin J Ethnomed Ethnophar (Chin)2018;27:63-65.
Wang WQ. The clinical observation of Gualou Xiebai Banxia Decoction in the treatment of angina pectoris. Hebei Med (Chin)2015;21:1033-1035.
Qin FH, Gua L, Xia B, et al. Gualou Xiebai Banxia Decoction combined Western medicine phlegm closed resistance of angina pectoris randomized controlled study. J Pract Tradit Chin Int Med(Chin) 2016;30:66-68.
Shan ZQ, Xu JJ. Effects of Gualou Xiebai Banxia Decoction myocardial revascularization in the treatment of angina pectoris of coronary heart disease of phlegm stagnation syndrome. World Chin Med (Chin) 2017;28:53-60.
Dai N, Qu J. Effect of Jiawei Gualou Xiebai Banxia Decoction on the blood lipid and plasma homocysteine on the patients with coronary heart disease. China Forei Med Treat (Chin) 2014;36:159-160.
Qin CJ. Research progress of treatment for thoracic obstruction with Gualou Xiebai Banxia Decoction. Chin J Urban Rural Enterp Hyg(Chin) 2017;32:23-25.
Li H, Li JF, Zhao QT. The myocardial protection mechanism of Gualou Xiebai Banxia Decoction. Guiding J Tradit Chin Med Pharm(Chin) 2014;20:39-41.
Li YJ, Zhou JW, Bian K. The mechanism research of Gualou Xiebai Banxia Decoction vasodilation. Pharmacol Clin Chin Mater Med(Chin) 2010;26:5-7.
Dai N, Qu J. The influence of Jiawei Gualou Xiebai Banxia Decoction to the TXB2 and 6-keto-PGF1α on the patients with chest obstruction belonging to phlegm congested syndrome. Chin J Gerontol (Chin) 2014;34:6771-6772.
Gong YL. Effect of Jiawei Gualou Xiebai Banxia Decoction on endothelial function in patients with phlegm congestion type coronary heat disease. Asia-Pacif Tradit Med (Chin) 2018;14:173-174.
Yan XS. Effect of Gualou Xiebai Banxia Decoction on MMP-9 and TIMP-1 in patients with phlegm congestion type chest stuffiness.Clini Res Prac (Chin) 2018;19:130-131.
Yang L, Zhang BT, Zhan JY, et al. Experimental study of Gualou Xiebai Banxia Decoction on the effect of VEGF and MVD expression in MIRI rats. J Hunan Univ Chin Med (Chin) 2015;35:10-12,36.
Zhang HM, Tang DL, Tong L, et al. Gualou Xiebai Banxia Decoction inhibits NF-kappa B-dependent inflammation in myocardial ischemia-reperfusion injury in rats. J Tradit Chin Med (Chin) 2011;31:338-343.
Jin HB, Duan XT, Zhang BT, et al. Effects of Gualou Xiebai Banxia Decoction on apoptosis and of cardiac myocytes and p38MAPK expression. J Emerg Tradit Chin Med (Chin) 2011;20:1942-1944.
Gou JE, Gao F, Hu YT, et al. The effect of Gualou Xiebai Banxia on inflammatory cytokines and the expression of ICAM-1 and VCAM-1 in AS model mice. J Jinan Univers (Chin) 2017;38:234-239.
Sun MH, Liu R. Exploring the clinical application of Xuefu Zhuyu Decoction based on ancient and modern literatures. Shandong J Tradit Chin Med (Chin) 2018;37:30-34.
Jo J, Leem J, Lee JM, et al. Herbal medicine (Hyeolbuchukeo-tang or Xuefu Zhuyu Decoction) for treating primary dysmenorrhoea:protocol for a systematic review of randomised controlled trials. BMJ Open 2017;15:e015056.
Yang XC, Xiong XJ, Yang GY, et al. Chinese patent medicine Xuefu Zhuyu Capsule for the treatment of unstable angina pectoris: a systematic review of randomized controlled trials. Complement Ther Med 2014;22:391-399.
Chu FY, Wang J, Yao KW, et al. Effect of Xuefu Zhuyu Capsule on the symptoms and signs and health-related quality of life in the unstable angina patients with blood-stasis syndrome after percutaneous coronary intervention: a randomized controlled trial.Chin J Integr Med 2010;16:399-405.
Zhang QQ. Curative effect of Xuefu Zhuyu Decoction combined with routine medical treatment in patients with acute coronary syndrome and influence on serum von Wilebrand factor and endothelin-1 levels. Chin Pharm (Chin) 2014;17:1360-1362.
Zhang YL. Effect of Xuefu Zhuyu Decoction on prothrombotic state in paients with unstable angina pectoris. J New Chin Med (Chin)2017;49:29-31.
Wu JH, Chen XY. The research progress of Xuefu Zhuyu decoction in modern pharmacology. Chin Tradit Pat Med (Chin) 2013;35:1054-1058.
Lin F, Chen BL, Wang YZ, et al. In vitro angiogenesis effect of Xuefu Zhuyu Decoction and vascular endothelial growth factor: A comparison study. Chin J Integr Med 2018;24:606-612.
Xu XL, Cai F, Lin F,et al. Roles of EphB4/ephrinB2 in angiogenesis induced by Xuefu Zhuyu Decoction. J Basic Chin Med (Chin)2016;22:362-364.
Zhang QY, Wang QL, Su JF, et al. Angiogenesis effects of Xuefu Zhuyu Decoction and VEGF protein expression of rats with acute myocardial ischemia. J Inform Tradit Chin Med (Chin) 2011;18:53-54.
Gao D, Chen WY, Lin W, et al. Study on function of VEGF pathway in promoting angiogenesis with Xuefu Zhuyu Decoction. China J Chin Mater Med (Chin) 2012;37:2622-2625.
Huang W, Dong C. Effects of Xuefu Zhuyu Decoction on the expression of matrix metalloproteianse-9 and tissue metalloproteinase inhibitor-1 in atherosclerotic rats. Med Res Educ (Chin) 2013;30:8-12.
Dong C, Huang W, Geng ZH, et al. Effect of Xuefu Zhuyu Decoction on intercellular adhesion molecule and lipid peroxidation of experimental atherosclerosis rats. J Hebei Univ 2012;32:650-654.
Wang H, Kang L, Wang L. Influence of Xuefu Zhuyu capsule on thrombelastography in rats with vascular endothelial injury. Chin J Arterioscler (Chin) 2016;24:547-550.
Xue M, Chen KJ, Ma XJ, et al. Effects of Xuefu Zhuyu Oral Liquid on hemorheology in patients with blood-stasis syndrome due to coronary disease and their relationship with human platelet antigen-3 polymorphism. J Chin Integr Med (Chin) 2008;6:1129-1135.
Liu XW. The effect of Xuefu Zhuyu Decoction on aortic morphology plaque stability and cytokines levels in the coronary heart disease rat. J Sichuan Tradit Chin Med (Chin) 2016;34:45-48.
Zhao XL, Zhang GH, Lv L. The effect of Xuefu Zhuyu Decoction on the proliferation of cardiac fibroblasts and collagen synthesis induced by TGF-β1. Guangdong Med J (Chin) 2016;37:1287-1289.
Liu BY, Song XL, Yi J, et al. Buyang Huanwu Decoction reduces infarct volume and enhances estradiol and estradiol receptor concentration in ovariectomized rats after middle cerebral artery occlusion. Chin J Integr Med 2014;20:782-786.
Peng Q. Clinical observation on the treatment of coronary heart disease with Buyang Huanwu Decoction. Guangming J Chin Med(Chin) 2018;33:2062-2064.
Liu M, Yang CX, Lu N, et al. Systemic evaluation of Buyang Huanwu Decoction in the treating stable angina pectoris. J Shandong Univ Tradit Chin Med (Chin) 2016;40:425-427.
Liu YM, Wei BT. Clinical observation on treating coronary with the Buyang Huanwu Decoction, Clin J Chin Med (Chin) 2014;6:97-98.
Xu ZY, Lei KJ, Xu HY. Effects of Buyang Huanwu Decoction on hemorheological parameters in the patients with coronary heart disease. Chin J Exp Tradit Med Formul (Chin) 2013;19:305-307.
Wang YZ, Wang B, Li F, et al. Therapeutic effects of Buyang Huanwu Decoction in patients with angina after coronary artery stenting. Chin Heart J (Chin) 2016;28:431-442.
Wu DN, Xiao Z, He FP, et al. Effects of Jiawei Buyang Huanwu Decoction on expression of lp-pla2, hs-crp and gdf-15 in patients with vascular spastic angina. J New Chin Med (Chin) 2018;50:57-59.
Zhao LH. The clinical effect of Buyang Huanwu Decoction on stable angina patients. Chin J Ration Dru Use (Chin) 2018;15:34-36.
Huang X, Li YF. Research progress on the mechanism of Buyang Huanwu Decoction against atherosclerosis. Chin J Tradi Chin Med Pharm (Chin) 2017;32:1187-1190.
Zhu BR, Wu HX. Research progress on the mechanism of Buyang Huanwu Decoction against atherosclerosis. Chin J Arterio (Chin)2017;25:99-104.
Han H. Effects of Jiawei Buyang Huanwu Decoction on ventricular remodeling and cardiac function in patients with myocardial infarction and qi deficiency and blood stasis. Mode J Integr Tradt Chin Med West Med (Chin) 2017;26:438-440.
Yang G, Fang Z, Liu Y, et al. Protective effects of Chinese traditional medicine Buyang Huanwu Decoction on myocardial injury. Evid Based Complement Alternat Med 2011;2011:930324.
Huang GQ, Zhou YC, Liu B, et al. Influence of Buyang Huanwu Decoction on myocardial cell apoptosis and heat shock protein 20 expression in myocardial infarction rats. J Guiyang Med Coll (Chin)2014;39:482-485,489.
Huang XF, Zhang T, Hua Y, et al. Effect of Buyang Huanwu Decoction on oxidative stress-induced neonatal rat cardiomyocytes apoptosis and expression of 5-LOX. J Trop Med (Chin) 2014;14:701-705,709.
Zhang HZ, Chen YQ, Geng YJ. Influence of Buyang Huanwu Decoction on the expression of aortic vascular cell adhesion molecule 1 mRNA in a rat atherosclerosis model. Chin J Tissue Eng Res (Chin) 2012;16:2776-2779.
Liu H. The clinical effect of Jiawei Wendan Decoction in the treatment of coronary heart disease. Clin J Chin Med (Chin) 2018;10:82-83.
Che YW, Yao KY, Xi YP, et al. Wendan Decoction for treatment of schizophrenia: a systematic review of randomized controlled trials. Chin J Integr Med 2016;22:302-310.
Zhao ZY, Zhang MX, Zou H, et al. The meta-analysis of Jiajian Wendan Decoction in the treatment of angina pectoris. J Liaoning Univer Tradi Chin Med (Chin) 2018;20:93-103.
Fan C, Ye F, Li Y, et al. The effect of Jiawei Huanglian Wendan Decoction on coronary heart disease and on C-reactive protein. World Chin Med (Chin) 2017;12:811-814.
Fan YJ. The clinical value of Jiawei Wendan Decoction in the treatment of coronary heart disease. Chin Foreign Med Res (Chin) 2015;13:62-63.
Lu XW, Gu YM. Effects of Wendan Decoction on the related risk factors in patients with turbid phlegm of coronary heart disease.Guangming J Chin Med (Chin) 2015;7:1-3.
Wei X, Wu WS. The clinic observation of Jiawei Wendan Decoction treating patients with stable angina and the effect on Hs-CRP and blood fats. Shanxi J Tradit Chin Med (Chin) 2017;38:276-279.
Li GH, Li P, Wang F, et al. The research of Wendan decoction and its associated prescriptions in the treatment of coronary heart disease. World J Integr Tradit West Med (Chin) 2010;5:259-262.
Xie GH, Zhang Y, Lu ZF. Effect of Jiawei Wendan Decoction on myocardial fibrosis and cardiac function in elderly patients with coronary heart disease after PCI. World Chin Med (Chin) 2018;13:878-881.
Zhang L, Li Y. Effect of Wendan Decoction on serum MMP-7 level of experimental coronary heart disease phlegm and blood stasis syndrome model in rabbits. Chin Med Mod Distance Educ Chin (Chin) 2012;10:158.
Zhang LL, Li Y. Effect of Wendan Decoction on serum IL-6 level of experimental coronary heart disease phlegm and blood stasis syndrome model in rabbits. Chin Mod Doct (Chin) 2012;50:1-2.
Xu L, Zhu QG. The clinical effect of Sini Decoction combined with diltiazem in treatment of variant angina pectoris. Shanxi J Chin Med(Chin) 2017;38:14-15.
Zhu Y, Zhao J, Han Q, et al. The effect and mechanism of Chinese herbal formula Sini Decoction in heart failure after myocardial infarction in rats. Evid Based Complement Alternat Med. 2018;27:5629342.
Zhuang C. Therapeutic evaluation and meta-analysis of Sini Decoction for treatment of angina pectoris. J Guangxi Univ Chin Med (Chin) 2013;16:132-135.
Mao Q, Jiang HX. The clinical observation of Sini Decoction combine with clopidogrel in treatment of angina pectoris. Mod J Integr Tradit Chin West Med (Chin) 2014;23:3915-3917.
Wu CT. Clinical effect of Sini Decoction in the treatment of elderly patients with coronary heart disease. Chin J Convalescent Med(Chin) 2017;26:634-635.
Liu JG, Peter K, Shi DZ, et al. Anti-inflammatory effects of the Chinese herbal formula Sini Decoction in myocardial infarction rats.Evid Based Complement Alternat Med 2014;2014:309378.
Wang JH. Discussion about the mechanism of Sini Decoction protective cardiovascular system. Clin J Tradit Chin Med (Chin) 2013;25:293-295.
Wu DK, Zheng JH, Zhang XC, et al. Literature-based metabolism mechanism study of Sini Decoction on myocardial infarction model.Tradit Chin Drug Res Clinic Pharma (Chin) 2017;28:1-6.
Liu J, Peter K, Shi D, et al. Traditional formula, modern application:Chinese medicine formula Sini Decoction improves early ventricular remodeling and cardiac function after myocardial infarction in rats. Evid Based Complement Alternat Med 2014;2014:141938.
Liu J, Peter K, Shi D, et al. Anti-inflammatory effects of the Chinese herbal formula Sini Decoction in myocardial infarction rats. Evid Based Complement Alternat Med 2014;2014:309378.
Zhang HH, Liu H, Xiang JY, et al. Study on molecular mechanism of Sini Decoction in treatment of myocardial ischemia based on network pharmacology. Mod Chin Med (Chin) 2018;20:265-277.
Cheng LF, Wang HL, Li M. Protective effect of Sini Decoction and its disassembled prescriptions on H9C2 cardiomyocytes of rats ischemia and hypoxia conditions. Pharma Clin Chin Mater Medica (Chin) 2018;34:28-32.
Yang Y, Xu P, Shi YP. Sini Decoction improves rat myocardial fibrosis by inhibiting Rho A/ROCK signaling pathway. Chin Tradit Patent Med (Chin) 2017;39:400-405.
Cheng HS, Yuan QH. Clinical research on Xiaoxianxiong Decoction in the treatment of acute myocardial infarction. J New Chin Med(Chin) 2015;47:16-17.
Zhang M, Lu GH. Overview of clinical application of Xiaoxianxiong Decoction. Clini J Tradi Chin Med (Chin) 2017;29:1962-1963.
Huang YC. Curative effect of using modified Xiaoxianxiong Decoction in the treatment of unstable angina pectoris and the action research on the resistin level in adipokines. J Sichuan Tradit Chin Med (Chin) 2016;34:74-76.
Xue RW, Guo YQ, Hou JJ, et al. Clinical dtudy on Xiaoxianxiong Decoction for treatment of refractory angina pectoris with qi stagnation and blood stasis syndrome. Chin J Informa Trad Chin Med (Chin) 2018;25:17-20.
Guan F, Guo X. Clinical observation of Xiaoxianxiong Decoction on phlegm-heat syndrome after coronary stenting. Hebei J Tradit Chin Med (Chin) 2018;24:110-112.
Zhou F, Yuan QL, Wang J. Curative efficacy of Jiawei Xiaoxianxiong Decoction on unstable angina with intermingled phlegm-heat syndrome and its effects on vascular endothelial function. Hebei J Tradit Chin Med (Chin) 2017;39:1297-1300.
Zeng JQ, Xu HJ, Ding XM, et al. Effect of Xiaoxianxiong Decoction on blood lipid, parameters of hemorheology and inflammation markers in atherosclerotic rats. Pharm Clin Chin Mater Med 2016;32:10-14.
Du F, Lu W. A discussion of treating arrhythmia of coronary heart disease with the Zhigancao Decoction. Clin Foreign Med Res (Chin)2017;15:36-37.
Chen PF, Chen XX, Qu HB, et al. Clinical analysis of Zhigancao Decoction in the treatment of angina pectoris. Cardiovasc Dis J Integr Tradit Chin West Med (Chin) 2015;3:28-29.
Ma Y, Zhu CZ. Clinical study on treatment of myocardial ischemia with Zhigancao Decoction. Acta Chin Med (Chin) 2017;32:2217-2228.
Li G. Effect of Zhigancao Decoction on hypotension after PCI of acute coronary syndrome. J Sichuan Tradi Chin Med (Chin) 2018;36:85-86.
Yi X, Guo YH. Study on the therapeutic effect of Zhigancao Decoction combine with Western medicine on arrhythmia of coronary heart disease. China Prac Med (Chin) 2018;13:105-106.
Wang Z, Xu RX. Effect of Zhigancao Decoction on electrocardiogram and serum enzymology in acute myocardial ischemia rats. Chin J Gerontol (Chin) 2014;34:3083-3085.
Yuan J. The effect of Zhigancao Decoction on the left cardiac function and antioxidative enzymes in ischemia reperfusion-injured rats. Lishizhen Med Mater Med Res (Chin) 2008;19:411-412.
Zou H, Zhang MX, Li H, et al. Meta-analysis of modified Zhishi Xiebai Guizhi Decoction for chest rheumatism. J Liaoning Univ Tradit Chin Med (Chin) 2017;19:108-111.
Zhu DJ, Lu S. Effect of Zhishi Xiebai Guizhi Decoction on Hc, hs-CRP in patients with unstable angina pectoris. J Liaoning Univer Tradi Chin Med (Chin) 2018;20:209-211.
Cai MY. Randomized control trail of Zhishi Xiebai Guizhi Decoction combined with Western medicien in the treatment of qi stagnaion and phlem type coronary heart disease angina pectoris. J Pract Tradit Chin Inter Med (Chin) 2016;30:63-65.
Dai F, Lu S, Su W, et al. Effect of Zhishi Xiebai Guizhi Decoction on MMP-9,TIMP-1 levels and gene expression in the patients with unstable angina. Chin J Exp Tradit Med Formulae (Chin) 2013;19:307-310.
Han YS, Hou ZT, Gong XM, et al. Effect of Zhishi Xiebai Guizhi Decoction on hermorrheology and oxygen free radicalsin acutemyocardial ischemia induced by isoproterenol in rat. Chin Foreign Med Treat (Chin) 2015;2:159-161.
Li NN, Shi YP. Effect of modified Zhishi Xiebai Guizhi Decoction on the expression of aquaporin in myocardial tissue of ischemia-reperfusion rats through AC/cAMP pathway. Chin J Arteriosclerosis(Chin) 2018;26:237-244.
Yuan R, Wang Y, Cong WH. Treatment of cardiovascular disease with Xiongshao capsule. Chin J Chin Mater Medic (Chin) 2017;42:640-643.
Zhang MF, Shen YQ. Advances in the pharmacological effects of pinellia ternata and its processed products on nervous and circulatory systems. Anti-infection Pharma (Chin) 2017;14:1643-1648.
Lui JN, Wen CX, Liu M, et al. Chemical component and pharmacological activity research progress of Snakegaurd Fruit. J Chin Med Mater (Chin) 2013;36:843-848.
Sun XY, Wu HH, Zhang P. Pharmacological activity research progress of snake gaurd fruit and long stamen onion bulb associated prescriptions. Chin Pharm (Chin) 2013;24:1044-1046.
Liu E, Han LT, Xue DQ. Research progress of Trichosanthes kirilowii Maxim and Allium Macrostemon bge. J Hubei Univ Chin Med (Chin) 2014;16:111-114.
Zhao X, Ning ZQ, Wang JW, et al. Efficacy and safety of Trichosanthes kirilowii Maxim in the traetment of coronary heart disease. Northwest Pharm J (Chin) 2016;31:86-91.
Xin QQ, Yang BR, Zhou HF, et al. Paeonifl orin promotes angiogenesis in a vascular insufficiency model of zebrafish in vivo and in human umbilical vein endothelial cells in vitro. Chin J Integr Med 2018;24:494-501.
Shao H, Zhao L, Chen F, et al. Efficacy of ligustrazine injection as adjunctive therapy for angina pectoris: a systematic review and meta-analysis. Med Sci Monit (Chin) 2015;21:3704-3715.
Jia M, Cui W. Hydroxysafflor yellow A cardiacprotection in ischemia-reperfusion (I/R) injury mainly via Akt/hexokinase independent of ERK/GSK-3β pathway. Biomed Pharmacother 2017;87:419-426.
Wei G, Yin Y, Duan JL, et al. Hydroxysafflor yellow A promotes neovascularization and cardiac function recovery through HO-1/VEGF-A/SDF-1α cascade. Biomed Pharmacother 2017;88:409-420.
0
浏览量
0
Downloads
1
CSCD
- Meta-XML下载
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
关联资源
相关文章
相关作者
相关机构
- 邮编：100091
- 联系电话：010-62886827, 62877592 传真：010-62874291
- 技术支持由北京北大方正电子有限公司提供 京ICP备05067934号-1
京公网安备11010802024621 - 本系统建议在Chrome、 IE9+ 以上版本浏览器阅读本站内容，360浏览器请切换至极速模式
- Cookies帮助我们提供服务并提供个性化体验。使用本网站，即表示您同意我们使用Cookies
